中国中西医结合急救杂志
中國中西醫結閤急救雜誌
중국중서의결합급구잡지
INTEGRATED TRADITIONAL CHINESE AND WESTERN MEDICINE IN PRACTICE OF CRITICAL CARE MEDICINE
2013年
5期
279-282
,共4页
陈华尧%吴同启%王克俭%乔丽君%孙明霞%傅元冬%陈畅泉%史肃育
陳華堯%吳同啟%王剋儉%喬麗君%孫明霞%傅元鼕%陳暢泉%史肅育
진화요%오동계%왕극검%교려군%손명하%부원동%진창천%사숙육
通腑法%重症肺炎%实热证%临床%小承气汤
通腑法%重癥肺炎%實熱證%臨床%小承氣湯
통부법%중증폐염%실열증%림상%소승기탕
Purging fu-organs therapy%Pneumonia,severe%Sthenia-heat%Clinic%Small chengqi decoction
目的探讨通腑法对重症肺炎实热证临床疗效的影响。方法按随机数字表法将71例重症肺炎实热证患者分为治疗组(35例)和对照组(36例)。两组均给予常规治疗,治疗组在对照组常规治疗基础上鼻饲小承气汤2周。比较两组临床肺部感染评分(CPIS评分)、多器官功能障碍评分(Marshall评分)、中医证候积分和28 d、60 d病死率。结果两组CPIS评分、Marshall评分及中医证候积分均随治疗时间延长而逐渐降低,治疗组CPIS评分和Marshall评分治疗后4 d低于对照组,差异有统计学意义〔CPIS评分(分):5.8±1.7比6.8±1.9,Marshall评分(分):5.3±2.3比6.6±2.7,均P<0.05〕,治疗后7 d、14 d两种评分也低于对照组(7 d CPIS评分:5.3±1.5比5.6±1.4,Marshall评分:5.1±1.9比5.7±1.8;14 d CPIS评分:3.9±1.7比4.4±2.3,Marshall评分:4.2±1.9比4.9±2.5),但差异均无统计学意义(均P>0.05)。治疗组中医证候积分(分)治疗后4、7、14 d均低于对照组,差异有统计学意义(4 d:7.6±2.3比10.6±2.7,7 d:7.4±2.5比9.2±2.1,14 d:6.1±1.9比8.3±2.4,均P<0.05)。对照组和治疗组患者28 d和60 d病死率比较差异均无统计学意义(28 d:16.7%比11.4%,60 d:25.0%比20.3%,均P>0.05)。结论通腑法可以进一步降低重症肺炎实热证患者CPIS评分和Marshall评分,改善重症肺炎患者证候。
目的探討通腑法對重癥肺炎實熱證臨床療效的影響。方法按隨機數字錶法將71例重癥肺炎實熱證患者分為治療組(35例)和對照組(36例)。兩組均給予常規治療,治療組在對照組常規治療基礎上鼻飼小承氣湯2週。比較兩組臨床肺部感染評分(CPIS評分)、多器官功能障礙評分(Marshall評分)、中醫證候積分和28 d、60 d病死率。結果兩組CPIS評分、Marshall評分及中醫證候積分均隨治療時間延長而逐漸降低,治療組CPIS評分和Marshall評分治療後4 d低于對照組,差異有統計學意義〔CPIS評分(分):5.8±1.7比6.8±1.9,Marshall評分(分):5.3±2.3比6.6±2.7,均P<0.05〕,治療後7 d、14 d兩種評分也低于對照組(7 d CPIS評分:5.3±1.5比5.6±1.4,Marshall評分:5.1±1.9比5.7±1.8;14 d CPIS評分:3.9±1.7比4.4±2.3,Marshall評分:4.2±1.9比4.9±2.5),但差異均無統計學意義(均P>0.05)。治療組中醫證候積分(分)治療後4、7、14 d均低于對照組,差異有統計學意義(4 d:7.6±2.3比10.6±2.7,7 d:7.4±2.5比9.2±2.1,14 d:6.1±1.9比8.3±2.4,均P<0.05)。對照組和治療組患者28 d和60 d病死率比較差異均無統計學意義(28 d:16.7%比11.4%,60 d:25.0%比20.3%,均P>0.05)。結論通腑法可以進一步降低重癥肺炎實熱證患者CPIS評分和Marshall評分,改善重癥肺炎患者證候。
목적탐토통부법대중증폐염실열증림상료효적영향。방법안수궤수자표법장71례중증폐염실열증환자분위치료조(35례)화대조조(36례)。량조균급여상규치료,치료조재대조조상규치료기출상비사소승기탕2주。비교량조림상폐부감염평분(CPIS평분)、다기관공능장애평분(Marshall평분)、중의증후적분화28 d、60 d병사솔。결과량조CPIS평분、Marshall평분급중의증후적분균수치료시간연장이축점강저,치료조CPIS평분화Marshall평분치료후4 d저우대조조,차이유통계학의의〔CPIS평분(분):5.8±1.7비6.8±1.9,Marshall평분(분):5.3±2.3비6.6±2.7,균P<0.05〕,치료후7 d、14 d량충평분야저우대조조(7 d CPIS평분:5.3±1.5비5.6±1.4,Marshall평분:5.1±1.9비5.7±1.8;14 d CPIS평분:3.9±1.7비4.4±2.3,Marshall평분:4.2±1.9비4.9±2.5),단차이균무통계학의의(균P>0.05)。치료조중의증후적분(분)치료후4、7、14 d균저우대조조,차이유통계학의의(4 d:7.6±2.3비10.6±2.7,7 d:7.4±2.5비9.2±2.1,14 d:6.1±1.9비8.3±2.4,균P<0.05)。대조조화치료조환자28 d화60 d병사솔비교차이균무통계학의의(28 d:16.7%비11.4%,60 d:25.0%비20.3%,균P>0.05)。결론통부법가이진일보강저중증폐염실열증환자CPIS평분화Marshall평분,개선중증폐염환자증후。
Objective To investigate the clinical efficacy of purging fu-organs traditional Chinese medicine (TCM)therapy for treatment of patients with severe pneumonia and sthenia-heat. Methods According to random number table method,71 patients with sthenia-heat of severe pneumonia were divided into a treatment group (35 cases)and a control group(36 cases). Conventional basic treatment was given to both groups,and additionally, small chengqi decoction was applied nasogastrically for the therapy in treatment group for 2 weeks. The clinical pulmonary infection score(CPIS),Marshall score,integration score of TCM syndromes and the mortalities in 28 days and 60 days were used to compare the clinical efficacy of the two groups. Results With the prolongation of treatment,the CPIS,Marshall score and integration score of syndromes in the two groups were gradually decreased. In treatment group,CPIS and Marshall scores were lower than those of control group on the 4th day ,and there were statistically significant differences(CPIS score:5.8±1.7 vs. 6.8±1.9,Marshall score:5.3±2.3 vs. 6.6±2.7,both P<0.05);the above 2 scores in treatment group were also lower than those of control group on the 7th and 14th day after treatment(7th day CPIS score:5.3±1.5 vs. 5.6±1.4,Marshall score:5.1±1.9 vs. 5.7±1.8;14th day CPIS score:3.9±1.7 vs. 4.4±2.3,Marshall score:4.2±1.9 vs. 4.9±2.5),but there were no statistically significant differences(all P>0.05). In addition,the integration scores of syndromes were significantly decreased on the 4th, 7th and 14th day in the treatment group significantly lower than those in the control group(4th day:7.6±2.3 vs. 10.6±2.7,7th day:7.4±2.5 vs. 9.2±2.1,14th day:6.1±1.9 vs. 8.3±2.4,all P<0.05). However,there were no statistically significant differences in mortality rates in 28 days and 60 days respectively between control group and treatment group(28 days:16.7% vs. 11.4%,60 days:25.0% vs. 20.3%,both P>0.05). Conclusion Purging fu-organs therapy not only can decrease the CPIS and Marshall scores of patients with sthenia-heat of severe pneumonia,but also can improve their syndromes.